Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001610717-26-000387 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 25, 2026 |
| Document | View SEC Filing |
Transactions
20
Total Shares
246,000
Total Value
$18,369,506.86
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 21, 2026 | Exercise/Conversion | 80,000 | $4.73 | $378,400.00 | 347,330 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 5,128 | $207.23 | $1,062,690.82 | 342,202 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 24,917 | $208.37 | $5,191,947.81 | 317,285 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 35,938 | $209.26 | $7,520,439.79 | 281,347 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 3,813 | $210.25 | $801,670.29 | 277,534 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 6,583 | $211.33 | $1,391,205.80 | 270,951 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 3,621 | $212.08 | $767,932.99 | 267,330 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 190 | $207.25 | $39,376.63 | 64,234 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 951 | $208.36 | $198,154.92 | 63,283 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 1,351 | $209.28 | $282,738.90 | 61,932 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 136 | $210.40 | $28,614.63 | 61,796 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 245 | $211.47 | $51,808.95 | 61,551 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 127 | $212.06 | $26,932.06 | 61,424 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 177 | $207.25 | $36,683.52 | 64,247 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 937 | $208.36 | $195,234.16 | 63,310 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 1,405 | $209.27 | $294,019.29 | 61,905 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 126 | $210.40 | $26,510.78 | 61,779 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 229 | $211.46 | $48,425.44 | 61,550 | Indirect | Trust | View Details | |
Director | Common Stock | โ | Aug 21, 2026 | Sale | 126 | $212.06 | $26,720.08 | 61,424 | Indirect | Trust | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 21, 2026 | Exercise/Conversion | 80,000 | $0.00 | $0.00 | 344,085 | Direct | โ | View Details |